In patients with low-trauma hip fracture, an annual infusion of zoledronic acid starting within 90 days of surgical repair of the fracture may decrease the risk of new fractures and improve survival.
In patients with low-trauma hip fracture, an annual infusion of zoledronic acid starting within 90 days of surgical repair of the fracture may decrease the risk of new fractures and improve survival, according to a study published online Sept. 17 in the New England Journal of Medicine.
Kenneth W. Lyles, MD, of the Duke University Medical Center in Durham, N.C., and colleagues randomly assigned 1,065 patients to receive either yearly intravenous zoledronic acid or placebo starting within 90 days after surgical repair of a hip fracture and followed them for a median of 1.9 years.
The researchers found that rates of any new clinical hip fracture were lower in the zoledronic acid group than in the placebo group (8.6 % versus 13.9%). They also found that the zoledronic acid group had a 28% lower risk of death from any cause, but that they also were more likely to experience side effects such as pyrexia, myalgia, and bone and musculoskeletal pain.
Lyles KW, Colón-Emeric CS,Magaziner JS, et al. Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture. N Engl J Med. 2007, Sep 26; [Epub ahead of print].
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More